178 related articles for article (PubMed ID: 5169924)
21. Leprosy research at the National Institutes of Health: experience with B.663 in the treatment of leprosy.
Williams TW; Mott PD; Wertlake PT; Rubio JB; Adler RC; Hill GJ; Suarez GP; Knight V
Int J Lepr; 1965; 33(3):Suppl:767-77. PubMed ID: 5322715
[No Abstract] [Full Text] [Related]
22. [Lampren in the treatment of leprosy].
Ahrens T
Schweiz Rundsch Med Prax; 1970 Mar; 59(11):387-9. PubMed ID: 5519711
[No Abstract] [Full Text] [Related]
23. Acute abdomen in a patient treated with lamprene.
Jagadeesan K; Visweswaran MK; Iyer KH
Int Surg; 1975 Apr; 60(4):208-9. PubMed ID: 1091577
[TBL] [Abstract][Full Text] [Related]
24. A field trial among leprosy patients in Nigeria with depot injections of dapsone and monoacetyldapsone.
Pieters FA; Woonink F; Zuidema J
Int J Lepr Other Mycobact Dis; 1988 Mar; 56(1):10-20. PubMed ID: 3373080
[TBL] [Abstract][Full Text] [Related]
25. Letter: Use of drugs and their effects on leprosy patients.
Graver V
Int J Lepr Other Mycobact Dis; 1974; 42(1):72. PubMed ID: 4472185
[No Abstract] [Full Text] [Related]
26. New drug for leprosy.
Br Med J; 1969 Mar; 1(5647):797-8. PubMed ID: 5774074
[No Abstract] [Full Text] [Related]
27. B.663 (Geigy 30. 320) in the treatment of leprosy. A preliminary report.
Devadason C
Acta Trop; 1969; 26(3):265-9. PubMed ID: 4391239
[No Abstract] [Full Text] [Related]
28. [Early diagnosis, therapy, and research in the control of leprosy].
Contreras Duenas F
Offentl Gesundheitswes; 1970 Dec; 32(12):667-71. PubMed ID: 4250373
[No Abstract] [Full Text] [Related]
29. Histochemistry of B663 pigmentation: ceroid-like pigmentation in macrophages.
Sakurai I; Skinsnes OK
Int J Lepr Other Mycobact Dis; 1977; 45(4):343-54. PubMed ID: 75860
[TBL] [Abstract][Full Text] [Related]
30. Therapy of leprosy.
Convit J; Browne SG; Languillon J; Pettit JH; Ramanujam K; Sagher F; Sheskin J; Tarabini G; de Souza Lima L; Tolentino JG; Waters MF; Bechelli LM; MartÃnez DomÃnguez V
Bull World Health Organ; 1970; 42(5):667-72. PubMed ID: 5311056
[TBL] [Abstract][Full Text] [Related]
31. [Activity of B663 in lepromatous leprosy. Therapeutic trial].
Pene P; Carrie J; Bourgeade A; Bolliot Y
Bull Soc Pathol Exot Filiales; 1971; 64(4):407-15. PubMed ID: 5172361
[No Abstract] [Full Text] [Related]
32. Chemotherapeutic trials in leprosy. 4. Dapsone (DDS) in low dosage in the treatment of lepromatous leprosy. A demonstration pilot study.
Pettit JH; Rees RJ
Int J Lepr Other Mycobact Dis; 1967; 35(2):140-8. PubMed ID: 5338958
[No Abstract] [Full Text] [Related]
33. Controlled comparison of therapeutic effects of DDS in combination with daily or once-monthly rifampicin in patients with lepromatous leprosy.
Ghosh S; McDougall AC; Hazra SK; Yawalkar SJ
Indian J Dermatol; 1981 Oct; 26(4):1-6. PubMed ID: 6754585
[No Abstract] [Full Text] [Related]
34. [Dapsone-induced photodermatitis in a patient with leprosy].
Fumey SM
Z Hautkr; 1988 Jan; 63(1):53-4. PubMed ID: 3354248
[TBL] [Abstract][Full Text] [Related]
35. A report on a controlled clinical trial with conventional and one third conventional dose of dapsone administered orally once a week in lepromatous patients.
Ramanujam K; Iyer CG; Ramu G
Lepr Rev; 1975 Jun; 46(2 Suppl):93-7. PubMed ID: 1100971
[No Abstract] [Full Text] [Related]
36. Chemical drug delivery systems: I. Preparation and evaluation of prodrugs of dapsone.
Kulkarni VM; Mishra DS
Indian J Lepr; 1985; 57(4):756-62. PubMed ID: 3835207
[TBL] [Abstract][Full Text] [Related]
37. Treatment of leprosy.
Ramanujam K
J Indian Med Assoc; 1973 Nov; 61(9):401-2. PubMed ID: 4791935
[No Abstract] [Full Text] [Related]
38. [Experimental studies in man on hyaluronidase inhibiting effect of clofazimine].
Mathies H; Ress U
Arzneimittelforschung; 1970 Dec; 20(12):1838-40. PubMed ID: 5537076
[No Abstract] [Full Text] [Related]
39. The treatment of erythema nodosum leprosum with B.663. A controlled study.
Pettit JH
Int J Lepr Other Mycobact Dis; 1967; 35(1):11-6. PubMed ID: 4290017
[No Abstract] [Full Text] [Related]
40. Fluorimetric screening of dapsone in urine for drug trials.
Balakrishnan S
Lepr India; 1980 Apr; 52(2):245-8. PubMed ID: 7005540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]